220 related articles for article (PubMed ID: 22461904)
41. Upregulation of E2F transcription factors in chemically induced mouse skin tumors.
Balasubramanian S; Ahmad N; Mukhtar H
Int J Oncol; 1999 Aug; 15(2):387-90. PubMed ID: 10402252
[TBL] [Abstract][Full Text] [Related]
42. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
Scott KA; Moore RJ; Arnott CH; East N; Thompson RG; Scallon BJ; Shealy DJ; Balkwill FR
Mol Cancer Ther; 2003 May; 2(5):445-51. PubMed ID: 12748306
[TBL] [Abstract][Full Text] [Related]
43. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
[TBL] [Abstract][Full Text] [Related]
44. Folic Acid Modulates DMBA/TPA-Induced Changes in Skin of Mice: A Study Relevant to Carcinogenesis.
Koul A; Kaur N; Chugh NA
J Diet Suppl; 2018 Jan; 15(1):72-87. PubMed ID: 28514181
[TBL] [Abstract][Full Text] [Related]
45. Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA).
Vähätupa M; Pemmari T; Junttila I; Pesu M; Järvinen TAH
J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904021
[TBL] [Abstract][Full Text] [Related]
46. Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate.
Lutz WK; Beland PE; Candrian R; Fekete T; Fischer WH
Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):44-8. PubMed ID: 8628919
[TBL] [Abstract][Full Text] [Related]
47. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
48. Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression.
Stern MC; Gimenez-Conti IB; Budunova I; Coghlan L; Fischer SM; DiGiovanni J; Slaga TJ; Conti CJ
Carcinogenesis; 1998 Jan; 19(1):125-32. PubMed ID: 9472703
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
50. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
51. IL-13Rα1 Suppresses Tumor Progression in Two-Stage Skin Carcinogenesis Model by Regulating Regulatory T Cells.
Salomaa T; Pemmari T; Määttä J; Kummola L; Salonen N; González-Rodríguez M; Parviainen L; Hiihtola L; Vähätupa M; Järvinen TAH; Junttila IS
J Invest Dermatol; 2022 Jun; 142(6):1565-1575.e17. PubMed ID: 34808240
[TBL] [Abstract][Full Text] [Related]
52. Hyperthermia and phorbol ester tumor promotion in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
[TBL] [Abstract][Full Text] [Related]
53. Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.
Goerttler K; Löhrke H; Hesse B
Carcinogenesis; 1980 Aug; 1(8):707-13. PubMed ID: 11272124
[TBL] [Abstract][Full Text] [Related]
54. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G
Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090
[TBL] [Abstract][Full Text] [Related]
55. DNA adducts, cell proliferation and papilloma latency time in mouse skin after repeated dermal application of DMBA and TPA.
Fischer WH; Beland PE; Lutz WK
Carcinogenesis; 1993 Jul; 14(7):1285-8. PubMed ID: 8330341
[TBL] [Abstract][Full Text] [Related]
56. Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Charron J; Khavari PA
Cancer Res; 2009 May; 69(9):3772-8. PubMed ID: 19383924
[TBL] [Abstract][Full Text] [Related]
57. DMBA/TPA-induced tumor formation is aggravated in human papillomavirus type 16 E6/E7 transgenic mouse skin.
Kim MO; Kim SH; Shin MJ; Yu DH; Kim BS; Chang KT; Lee S; Park YB; Lee TH; Ryoo ZY
Oncol Res; 2007; 16(7):325-32. PubMed ID: 17518270
[TBL] [Abstract][Full Text] [Related]
58. Involvement of retrotransposition of long interspersed nucleotide element-1 in skin tumorigenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate.
Okudaira N; Goto M; Yanobu-Takanashi R; Tamura M; An A; Abe Y; Kano S; Hagiwara S; Ishizaka Y; Okamura T
Cancer Sci; 2011 Nov; 102(11):2000-6. PubMed ID: 21827582
[TBL] [Abstract][Full Text] [Related]
59. CENP-50 is required for papilloma development in the two-stage skin carcinogenesis model.
Saito M; Kagawa N; Okumura K; Munakata H; Isogai E; Fukagawa T; Wakabayashi Y
Cancer Sci; 2020 Aug; 111(8):2850-2860. PubMed ID: 32535988
[TBL] [Abstract][Full Text] [Related]
60. Porphyrin-mediated photosensitization has a weak tumor promoting activity in mouse skin: possible role of in situ-generated reactive oxygen species.
Giri U; Iqbal M; Athar M
Carcinogenesis; 1996 Sep; 17(9):2023-8. PubMed ID: 8824530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
